// App-Quantinova.ai

: Telomere Length Predicts for Outcome to FCR Chemoimmunotherapy in CLL

Researchers

Presenter

  • Kevin Norris

Principal Investigators

  • Peter Hillmen

  • Andy Rawstron

  • Robert K. Hills

  • Duncan M Baird

  • Chris Pepper

  • Christopher Fegan

Medical Centers

  • Institute of Cancer & Genetics, Cardiff University, Cardiff, Wales, United Kingdom

  • St. James's University Hospital, Leeds, United Kingdom

  • Leeds Teaching Hospital Trust, Leeds, UK

  • Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom

  • Division of Cancer and Genetics, Cardiff University, Cardiff, United Kingdom

  • Brighton and Sussex Medical School, University of Sussex, Brighton, United Kingdom

  • Cardiff and Vale University Health Board, Cardiff,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cluster of Differentiation 38

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • fludarabine tablet

  • Rituximab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved